The use of SGLT2 vs DPP4 inhibitors was linked to reduced cardiovascular and renal risks among patients with comorbid SLE and T2D.
10h
Boing Boing on MSN2020 paper pushing bogus Covid treatment finally retractedA 2020 paper that caused a shortage of an anti-malarial drug also used to treat autoimmune disorders like lupus was just ...
11h
Tasting Table on MSNHere's Exactly What Dunkin's Eggs Are Made Out OfIf you're wondering what the eggs in your patty are actually made of, you might be surprised that there's a bit more in there ...
Viatris Inc. today announced the publication of Phase 2b CARE study results evaluating the efficacy and safety of cenerimod in adults with moderate-to-severe systemic lupus erythematosus (SLE). The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results